Resistance in Colorectal Cancer by Ryan B. Corcoran, MD, PhD

Dr Ryan Corcoran from MGH talks about #BRAF mutated colorectal cancer updates in this #DocTalkПодробнее

Dr Ryan Corcoran from MGH talks about #BRAF mutated colorectal cancer updates in this #DocTalk

Ryan Corcoran, MD, explains the need for the MRD test in CRC and whether its ready for prime timeПодробнее

Ryan Corcoran, MD, explains the need for the MRD test in CRC and whether its ready for prime time

Frontiers in Oncology: Ryan Corcoran, MDПодробнее

Frontiers in Oncology: Ryan Corcoran, MD

Dr. Corcoran on Targeting HER2 Amplification in CRCПодробнее

Dr. Corcoran on Targeting HER2 Amplification in CRC

2016 WMIF | First Look: Ryan Corcoran, MD, PhD, MGHПодробнее

2016 WMIF | First Look: Ryan Corcoran, MD, PhD, MGH

Dr. Corcoran on the Utility of Regorafenib in CRCПодробнее

Dr. Corcoran on the Utility of Regorafenib in CRC

Dr. Corcoran on Immunotherapy for Microsatellite Stable/Instable CRCПодробнее

Dr. Corcoran on Immunotherapy for Microsatellite Stable/Instable CRC